Nurix Therapeutics (NRIX) Cash from Investing Activities (2019 - 2026)
Nurix Therapeutics' Cash from Investing Activities was $31.58 million in fiscal Q3 2026 (quarter ended Aug 31, 2026), down 37.4% from $50.48 million a year earlier and down 66.0% from the prior quarter.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Cash from Investing Activities (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Nurix Therapeutics' Cash from Investing Activities was $1.1 million through Aug 31, 2026, down 83.6% year-over-year; for FY2025 (ended Nov 30, 2025), it was $147.85 million.
- In earlier fiscal years, Cash from Investing Activities was -$257.71 million in FY2024, $68.3 million in FY2023 (+151.1%), $27.2 million in FY2022 and -$108.25 million in FY2021.
- Quarterly Cash from Investing Activities has moved between -$140.82 million (fiscal Q4 2024) and $93 million (fiscal Q2 2026) over five years.
- Per Business Quant data, NRIX's Cash from Investing Activities in the three fiscal quarters before Q3 2026 was $93 million (Q2 2026), -$123.83 million (Q1 2026) and $346,000 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -8.30 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -2.71 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -10.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -1.32 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -1.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -649.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -244.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | -2.03 Bn |
| 10 | Nurix Therapeutics | 1.73 Bn | -891.35 Mn | - | 31.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 31.58 Mn |
| May 31, 2026 | 93.00 Mn |
| Feb 28, 2026 | -123.83 Mn |
| Nov 30, 2025 | 346,000.00 |
| Aug 31, 2025 | 50.48 Mn |
| May 31, 2025 | 71.50 Mn |
| Feb 28, 2025 | 25.53 Mn |
| Nov 30, 2024 | -140.82 Mn |
| Aug 31, 2024 | -21.34 Mn |
| May 31, 2024 | -131.07 Mn |
| Feb 29, 2024 | 35.51 Mn |
| Nov 30, 2023 | -14.37 Mn |
| Aug 31, 2023 | 22.78 Mn |
| May 31, 2023 | 43.83 Mn |
| Feb 28, 2023 | 16.07 Mn |
| Nov 30, 2022 | 55.01 Mn |
| Aug 31, 2022 | -63.08 Mn |
| May 31, 2022 | -4.77 Mn |
| Feb 28, 2022 | 40.03 Mn |
| Nov 30, 2021 | -36.52 Mn |
API Access
Nurix Therapeutics Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();